{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:54:17Z","timestamp":1791078857215,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1067\/mjd.2002.124607","type":"journal-article","created":{"date-parts":[[2002,10,24]],"date-time":"2002-10-24T21:10:33Z","timestamp":1035493833000},"page":"672-684","source":"Crossref","is-referenced-by-count":154,"title":["Optimizing bexarotene therapy for cutaneous T-cell lymphoma"],"prefix":"10.1067","volume":"47","author":[{"given":"Rakhshandra","family":"Talpur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staci","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narin","family":"Apisarnthanarax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Breuer-McHam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Duvic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2002.124607_bib1","first-page":"276","article-title":"Mycosis fungoides and S?zary syndrome","volume":"26","author":"Kim","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1067\/mjd.2002.124607_bib2","first-page":"154","article-title":"Epidemiology of mycosis fungoides","volume":"13","author":"Weinstock","year":"1994","journal-title":"Semin Dermatol"},{"key":"10.1067\/mjd.2002.124607_bib3","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJM198912283212603","article-title":"A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the treatment of mycosis fungoides","volume":"321","author":"Kaye","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2002.124607_bib4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0190-9622(99)70491-3","article-title":"Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients","volume":"40","author":"Zackheim","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.124607_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.135.1.26","article-title":"Clinical characteristics and long-term outcome of patients with generalized patch or plaque (T2) mycosis fungoides","volume":"135","author":"Kim","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.124607_bib6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-121-8-199410150-00007","article-title":"Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and S?zary syndrome)","volume":"121","author":"Bunn","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1067\/mjd.2002.124607_bib7","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1200\/JCO.1991.9.7.1298","article-title":"Mycosis fungoides and S?zary syndrome: a review of pathogenesis, diagnosis and therapy","volume":"9","author":"Kuzel","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1067\/mjd.2002.124607_bib8","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archderm.1995.01690210033005","article-title":"Prognostic factors in erythrodermic mycosis fungoides and the S?zary syndrome","volume":"131","author":"Kim","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.124607_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM198702053160603","article-title":"Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy","volume":"316","author":"Edelson","year":"1987","journal-title":"N Eng J Med"},{"key":"10.1067\/mjd.2002.124607_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0733-8635(05)70155-8","article-title":"Emerging new therapies for cutaneous T-cell lymphoma","volume":"18","author":"Duvic","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1067\/mjd.2002.124607_bib11","first-page":"581","article-title":"Phase 2 and 3 clinical trial of oral bexarotene (Targretin Capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma","volume":"137","author":"Duvic","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.124607_bib12","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1200\/JCO.2001.19.9.2456","article-title":"Bexarotene is effective and safe for treatment of refractory advanced stage cutaneous T-cell lymphoma: multinational phase II-III trial results","volume":"19","author":"Duvic","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1067\/mjd.2002.124607_bib13","first-page":"97a","article-title":"Oral bexarotene benefits patients with refractory advanced stage CTCL","volume":"94","author":"Hymes","year":"1999","journal-title":"Blood"},{"key":"10.1067\/mjd.2002.124607_bib14","first-page":"1405","article-title":"Fas-mediated apoptosis in tumor formation and defense","volume":"378","author":"Hug","year":"1997","journal-title":"Biol Chem"},{"key":"10.1067\/mjd.2002.124607_bib15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJM199904083401404","article-title":"Central hypothyroidism associated with retinoid X receptor-selective","volume":"340","author":"Sherman","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2002.124607_bib16","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"12","author":"Kwak","year":"2000","journal-title":"Nat Med"},{"key":"10.1067\/mjd.2002.124607_bib17","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM199908123410707","article-title":"Drug treatment of lipid disorders","volume":"341","author":"Knopp","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2002.124607_bib18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0095-4543(05)70164-0","article-title":"Cardiovascular disease: hyperlipidemia","volume":"27","author":"Yu","year":"2000","journal-title":"Prim Care"},{"key":"10.1067\/mjd.2002.124607_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1182\/blood.V89.1.32","article-title":"Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V-beta gene expansion","volume":"89","author":"Jackow","year":"1997","journal-title":"Blood"},{"key":"10.1067\/mjd.2002.124607_bib20","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0190-9622(89)70051-7","article-title":"Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T-cell lymphoma","volume":"20","author":"Vonderheid","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.124607_bib21","first-page":"725","article-title":"Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas","volume":"63","author":"Bunn","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1067\/mjd.2002.124607_bib22","unstructured":"Morgan M, Maloney D, Duvic M. Low serum calcium and magnesium in cutaneous T-cell lymphoma patients with advanced disease. Lymphoma Leukemia. In press."},{"key":"10.1067\/mjd.2002.124607_bib23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1309\/U1Y6-J4AG-5M4M-7AYV","article-title":"Absence of CD26 is a useful marker for the diagnosis of mycosis fungoides involvement of peripheral blood","volume":"115","author":"Jones","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1067\/mjd.2002.124607_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1067\/mjd.2002.118538","article-title":"Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas","volume":"46","author":"Vonderheid","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.124607_bib25","year":"2001"},{"key":"10.1067\/mjd.2002.124607_bib26","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1021\/jm00016a018","article-title":"Design and synthesis of potent retinoid X receptor selective ligands that induces apoptosis in leukemic cells","volume":"38","author":"Boehm","year":"1995","journal-title":"J Med Chem"},{"key":"10.1067\/mjd.2002.124607_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ijc.2910570115","article-title":"Synergistic effects of retinoids and interferon alpha on tumor-induced angiogenesis, anti-angiogenic effect of HPV-harboring tumor-cell lines","volume":"57","author":"Majewski","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1067\/mjd.2002.124607_bib28","unstructured":"Targretin (bexarotene) capsules product monograph. Ligand Pharmaceuticals; 2000."}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202001469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202001469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:15:24Z","timestamp":1583885724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962202001469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["S0190962202001469"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2002.124607","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}